Vanta Bioscience (540729.BO) Stock Price

Vanta Bioscience Price

CLOSED
19.64INR-1.03 (-5.11 %)
Market closed

Revenue at Vanta Bioscience has contracted by 9.6% per year over the past 7 years to 19.64 M INR. Earnings per share have grown at 29.3% per year over the last 4 years. For Vanta Bioscience, the net margin of -243.2% is down versus 4.5% a few years ago. The stock trades about 33% above its 52-week low.

Vanta Bioscience stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Vanta Bioscience over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vanta Bioscience stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vanta Bioscience's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Vanta Bioscience Stock Price History
DateVanta Bioscience Price
8/13/202619.64 INR
8/12/202620.67 INR
8/11/202621.75 INR
8/10/202621.75 INR
8/7/202621.75 INR
8/6/202622.83 INR
8/5/202622.83 INR
8/4/202624.03 INR
8/3/202624.03 INR
7/30/202625.29 INR
7/29/202625.29 INR
7/28/202625.29 INR
7/27/202625.29 INR
7/24/202625.29 INR
7/23/202625.29 INR
7/22/202625.29 INR
7/21/202625.29 INR
7/20/202625.29 INR
7/17/202625.29 INR
7/16/202625.29 INR
7/15/202625.29 INR
7/14/202625.29 INR
7/13/202625.29 INR
7/10/202625.29 INR
7/9/202625.29 INR
7/8/202625.29 INR
7/7/202625.29 INR
7/6/202625.29 INR
7/3/202624.09 INR
7/2/202624.09 INR
7/1/202624.09 INR
6/30/202624.09 INR
6/29/202624.09 INR
6/25/202624.09 INR
6/24/202625.35 INR
6/23/202625.35 INR
6/22/202625.35 INR
6/19/202624.93 INR
6/18/202624.72 INR
6/17/202623.75 INR
6/16/202623.75 INR
6/15/202623.60 INR
6/12/202623.12 INR
6/11/202622.02 INR
6/10/202622.02 INR
6/9/202622.02 INR
6/8/202622.02 INR
6/5/202622.02 INR
6/4/202623.17 INR
6/3/202622.07 INR
6/2/202623.23 INR
6/1/202623.23 INR
5/29/202623.23 INR
5/28/202624.45 INR
5/27/202624.45 INR
5/26/202624.45 INR
5/25/202624.45 INR
5/22/202622.70 INR
5/21/202619.56 INR
5/20/202617.01 INR
5/19/202617.01 INR
5/18/202617.01 INR
5/15/202618.00 INR
5/14/202618.00 INR
5/13/202618.00 INR
5/12/202615.58 INR
5/11/202615.58 INR
5/8/202615.58 INR
5/7/202618.50 INR
5/6/202618.50 INR
5/5/202618.30 INR
5/4/202618.30 INR
5/1/202616.25 INR
4/30/202616.25 INR
4/29/202616.25 INR
4/28/202616.25 INR
4/27/202618.50 INR
4/24/202618.50 INR
4/23/202618.50 INR
4/22/202618.19 INR
4/21/202618.19 INR
4/20/202618.20 INR
4/17/202618.20 INR
4/16/202618.22 INR
4/15/202618.22 INR
4/13/202618.22 INR
4/10/202618.22 INR
4/9/202615.20 INR
4/8/202615.20 INR
4/7/202615.20 INR
4/6/202615.15 INR
4/2/202615.15 INR
4/1/202615.15 INR
3/30/202615.15 INR
3/27/202614.90 INR
3/25/202616.69 INR
3/24/202614.72 INR
3/23/202615.06 INR
3/20/202616.36 INR
3/19/202617.45 INR
3/18/202617.45 INR
3/17/202617.40 INR
3/16/202617.40 INR
3/13/202617.20 INR
3/12/202618.50 INR
3/11/202619.40 INR
3/10/202620.60 INR
3/9/202620.60 INR
3/6/202620.60 INR
3/5/202620.60 INR
3/4/202620.60 INR
3/2/202623.00 INR
2/27/202623.00 INR
2/26/202623.00 INR
2/25/202623.00 INR
2/24/202622.01 INR
2/23/202622.01 INR
2/20/202622.01 INR
2/19/202620.30 INR
2/18/202617.00 INR
2/17/202616.26 INR
2/16/202619.89 INR
2/13/202619.89 INR
2/12/202619.89 INR
2/11/202619.89 INR
2/10/202619.89 INR
2/9/202619.89 INR
2/6/202619.50 INR
2/5/202619.50 INR
2/4/202619.50 INR
2/3/202619.50 INR
2/2/202619.50 INR
1/30/202619.50 INR
1/29/202619.50 INR
1/28/202619.50 INR
1/27/202619.50 INR
1/23/202619.50 INR
1/22/202619.50 INR
1/21/202619.50 INR
1/20/202621.00 INR
1/19/202621.00 INR
1/16/202621.50 INR
1/15/202621.50 INR
1/14/202621.50 INR
1/13/202621.50 INR
1/12/202621.00 INR
1/9/202621.00 INR
1/8/202621.00 INR
1/7/202622.25 INR
1/6/202623.50 INR
1/5/202623.50 INR
1/2/202623.50 INR
1/1/202623.50 INR
12/31/202523.50 INR
12/30/202522.60 INR
12/29/202520.59 INR
12/26/202518.72 INR
12/24/202518.72 INR
12/23/202520.79 INR
12/22/202520.79 INR
12/19/202520.08 INR
12/18/202520.49 INR
12/17/202520.49 INR
12/16/202520.49 INR
12/15/202520.49 INR
12/12/202520.49 INR
12/11/202519.80 INR
12/10/202519.80 INR
12/9/202519.84 INR
12/8/202519.84 INR
12/5/202519.56 INR
12/4/202521.45 INR
12/3/202522.56 INR
12/2/202522.56 INR
12/1/202523.68 INR
11/28/202523.68 INR
11/27/202522.57 INR
11/26/202522.57 INR
11/25/202522.57 INR
11/24/202523.75 INR
11/21/202523.75 INR
11/20/202526.22 INR
11/19/202526.22 INR
11/18/202526.22 INR
11/17/202526.22 INR
11/14/202526.22 INR
11/13/202526.22 INR
11/12/202526.22 INR
11/11/202526.22 INR
11/10/202526.22 INR
11/7/202527.60 INR
11/6/202527.69 INR
11/4/202526.69 INR
11/3/202524.93 INR
10/31/202523.47 INR
10/30/202521.66 INR
10/29/202524.00 INR
10/28/202524.00 INR
10/27/202524.83 INR
10/24/202525.20 INR
10/23/202525.20 INR
10/21/202527.99 INR
10/20/202527.99 INR
10/17/202526.00 INR
10/16/202525.57 INR
10/15/202524.88 INR
10/14/202522.65 INR
10/13/202522.65 INR
10/10/202525.16 INR
10/9/202527.95 INR
10/8/202525.41 INR
10/7/202525.41 INR
10/6/202524.20 INR
10/3/202523.05 INR
10/1/202524.26 INR
9/30/202524.26 INR
9/29/202524.26 INR
9/26/202524.26 INR
9/25/202523.11 INR
9/24/202524.23 INR
9/23/202525.00 INR
9/22/202525.86 INR
9/19/202524.63 INR
9/18/202523.46 INR
9/17/202522.35 INR
9/16/202522.35 INR
9/15/202522.35 INR
9/12/202523.52 INR
9/11/202522.95 INR
9/10/202524.15 INR
9/9/202523.57 INR
9/8/202523.57 INR
9/5/202523.11 INR
9/4/202522.03 INR
9/3/202522.03 INR
9/2/202523.18 INR
9/1/202523.18 INR
8/29/202523.18 INR
8/28/202524.40 INR
8/26/202525.64 INR
8/25/202525.64 INR
8/22/202525.64 INR
8/21/202525.64 INR
8/20/202525.64 INR
8/19/202525.64 INR
8/18/202525.64 INR
Access this data via the Eulerpool API
Get Free API Key

Vanta Bioscience Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
39.86 M INR
4.59 M INR
273,000.00 INR
Jan 1, 2019
124.25 M INR
30.23 M INR
6.96 M INR
Jan 1, 2020
141.43 M INR
31.80 M INR
10.05 M INR
Jan 1, 2021
100.38 M INR
27.48 M INR
4.50 M INR
Jan 1, 2022
96.88 M INR
21.52 M INR
882,100.00 INR
Jan 1, 2023
62.76 M INR
-50.64 M INR
-64.81 M INR
Jan 1, 2024
97.23 M INR
-31.84 M INR
-23.16 M INR
Jan 1, 2025
19.64 M INR
-86.72 M INR
-47.75 M INR

Vanta Bioscience Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 15, 2026, 7:15 AM
 
REVENUEM INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM INR
EBITM INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
SHARESM
20182019202020212022202320242025
39.00124.00141.00100.0096.0062.0097.0019.00
–217.9513.71-29.08-4.00-35.4256.45-80.41
92.3189.5291.4992.0092.7185.4892.7831.58
36.00111.00129.0092.0089.0053.0090.006.00
4.0030.0031.0027.0021.00-50.00-31.00-86.00
10.2624.1921.9927.0021.88-80.65-31.96-452.63
–6.0010.004.00–-64.00-23.00-47.00
––66.67-60.00––-64.06104.35
5.466.316.316.316.316.316.316.31
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Vanta Bioscience generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vanta Bioscience retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vanta Bioscience's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Vanta Bioscience has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vanta Bioscience's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Vanta Bioscience stock margins

The Vanta Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vanta Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vanta Bioscience.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
91.91 %
11.51 %
0.68 %
Jan 1, 2019
89.39 %
24.33 %
5.61 %
Jan 1, 2020
91.66 %
22.49 %
7.10 %
Jan 1, 2021
91.84 %
27.37 %
4.48 %
Jan 1, 2022
92.75 %
22.22 %
0.91 %
Jan 1, 2023
84.90 %
-80.69 %
-103.26 %
Jan 1, 2024
92.59 %
-32.75 %
-23.82 %
Jan 1, 2025
32.01 %
-441.66 %
-243.18 %

Vanta Bioscience Stock Revenue, EBIT, Earnings per Share

The Vanta Bioscience earnings per share therefore indicates how much revenue Vanta Bioscience has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
7.30 INR
0.84 INR
0.05 INR
Jan 1, 2019
19.68 INR
4.79 INR
1.10 INR
Jan 1, 2020
22.41 INR
5.04 INR
1.59 INR
Jan 1, 2021
15.90 INR
4.35 INR
0.71 INR
Jan 1, 2022
15.35 INR
3.41 INR
0.14 INR
Jan 1, 2023
9.94 INR
-8.02 INR
-10.27 INR
Jan 1, 2024
15.40 INR
-5.04 INR
-3.67 INR
Jan 1, 2025
3.11 INR
-13.74 INR
-7.56 INR

Vanta Bioscience business model & stock analysis

Vanta Bioscience Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Vanta Bioscience historical P/E ratio, EBIT multiple, and P/S ratio

Vanta Bioscience annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Vanta Bioscience shares outstanding

The number of shares of Vanta Bioscience was 6.31 M in 2025. This indicates how many shares Vanta Bioscience is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
5.46 M Stocks
Jan 1, 2019
6.31 M Stocks
Jan 1, 2020
6.31 M Stocks
Jan 1, 2021
6.31 M Stocks
Jan 1, 2022
6.31 M Stocks
Jan 1, 2023
6.31 M Stocks
Jan 1, 2024
6.31 M Stocks
Jan 1, 2025
6.31 M Stocks
Price targets and forecasts for Vanta Bioscience are not yet available.

Vanta Bioscience shareholder structure

% Name
49.02250%
Mulakala (Mohan Krishna)
Mulakala (Mohan Krishna)
12.06751%
Mulakala (Dopesh Raja)
Mulakala (Dopesh Raja)
7.34880%
Simhadri (Chandra Sekhar Rao)
Simhadri (Chandra Sekhar Rao)
1.36076%
menezes (Emily Bosco)
menezes (Emily Bosco)
1.26723%
Simhadri (Soumya)
Simhadri (Soumya)
1.12658%
Chintapatla (Shravan)
Chintapatla (Shravan)

Vanta Bioscience Executives and Management Board

7 members · avg. age 39 · 29 % women

SR

Mr. Sadhanala Rao

Chief Executive Officer, Whole Time Director

6.00 M INR

Management

DM

Mr. Dopesh Mulakala (39)

Managing Director, Director · since 2016

3.00 M INR
AK

Mr. Annabatula Kumar

Chief Financial Officer

–
SC

Ms. Sangeetha Choudhary

Compliance Officer, Company Secretary

–

Board of Directors

PA

Dr. Padmanabhuni Appaji

Independent Director

–
YD

Dr. Yogeswara Danda

Independent Director

–
KG

Dr. Kathyayani Gonuguntla

Independent Director

–

Frequently asked questions about Vanta Bioscience

Converted at the current exchange rate, the Vanta Bioscience share trades at 0.18 EUR (19.64 INR).

No history available for Vanta Bioscience.

The revenue cannot currently be calculated for Vanta Bioscience.

The profit cannot currently be calculated for Vanta Bioscience.

The P/E ratio cannot be calculated for Vanta Bioscience at the moment.

The P/S cannot be calculated for Vanta Bioscience currently.

The Eulerpool Quality Score for Vanta Bioscience is 1/10.

The ISIN of Vanta Bioscience is INE695X01011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Vanta Bioscience is 540729.BO. The ticker symbol is used to trade Vanta Bioscience shares on the stock exchange.

Vanta Bioscience paid dividends every year for the past 0 years.

Vanta Bioscience is assigned to the 'Health' sector.

The dividends of Vanta Bioscience are distributed in INR.

All fundamentals and in-depth analysis of Vanta Bioscience

Our stock analysis for Vanta Bioscience stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vanta Bioscience. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Vanta Bioscience Stock
Vanta Bioscience Revenue→
Vanta Bioscience Stock
Vanta Bioscience Net Income→
Vanta Bioscience Stock
Vanta Bioscience P/E→
Vanta Bioscience Stock
Vanta Bioscience P/S→
Vanta Bioscience Stock
Vanta Bioscience EBIT→
Vanta Bioscience Stock
Vanta Bioscience Dividend→
Vanta Bioscience Stock
Vanta Bioscience Directors Dealings→
Vanta Bioscience Stock
Vanta Bioscience Stocks→
Vanta Bioscience Stock
Vanta Bioscience Market capitalization→
Vanta Bioscience Stock
Vanta Bioscience Debt→
Vanta Bioscience Stock
Vanta Bioscience Liabilities→
Vanta Bioscience Stock
Vanta Bioscience Equity→
Vanta Bioscience Stock
Vanta Bioscience AAQS→
Vanta Bioscience Stock
Vanta Bioscience Employees→
Vanta Bioscience Stock
Vanta Bioscience ROE→
Vanta Bioscience Stock
Vanta Bioscience ROA→
Vanta Bioscience Stock
Vanta Bioscience ROCE→
Vanta Bioscience Stock
Vanta Bioscience News→
Vanta Bioscience Stock
Vanta Bioscience Analyst Price Targets→

Health Stocks

Varex ImagingVanda PharmaceuticalsVasa DenticityValue HR CoVasoValue Added Technology CoVaxartValneva SE ADRVaxCell Biotherapeutics CoValnevaVaxcyteValiRxAll Stocks A–Z →